A US-based rheumatologist shares their treatment paradigm for psoriatic arthritis patients, their approach to prescribing the anti-TNF class post-Humira patent cliff, and their opinions on key pipeline therapies and new mechanisms.

This interview was conducted on 30 June, 2025.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900.